Meeting report VLPNPV: Session 6: Development and characterization.

Clicks: 231
ID: 75432
2014
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
rutkowska2014meetinghuman Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rutkowska, Daria;
Journal human vaccines & immunotherapeutics
Year 2014
DOI
10.4161/21645515.2014.979645
URL
Keywords
who, world health organization im, intramuscular ms2 hiv, human immunodeficiency virus apc, antigen presenting cells cge, capillary gel electrophoresis clp, core-like particle gfp, green fluorescent protein h7n9 ha, hemagglutinin hai, hemagglutination-inhibition hbcag hbcag, hepatitis b core antigen il-1β, interleukin 1β iga/igg, immunoglobulin a/immunoglobulin g na, neuraminidase niv, nipah virus nov, norovirus rv vp6 rv, rotavirus s. aureus, staphylococcus aureus sf9, spodoptera frugiperda 9 vlp vlp, virus-like particle vp2/vp6, viral protein 2/viral protein 6 cgmp, current good manufacturing practices hmts, hollow microstructured transdermal system mrna, messenger rna smts, solid microstructured transdermal system

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.